A survey of cost, access and outcomes for cannabinoid‐based medicinal product use by Australians with endometriosis
article
OA: hybrid
CC0
⤵ 3 in-corpus citations
AI-generated summary
This survey of 192 Australians with endometriosis found high monthly costs for medicinal cannabis, leading many to reduce dosage or use illicit products despite prescriptions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a 'cannabis clinic' doctor, incurring an initial consultation cost of $100-$200+ (10.2% Medicare bulk-billed) and median cannabinoid medicine costs of $300AUD per month. Cost was a major barrier to access, necessitating reducing dosage (76.1%) and/or consuming illicit cannabis (42.9%), despite a prescription. Most (77%) medical consumers used two or more cannabis products, with delta-9-tetrahydrocannabinol predominant oil and flower products most frequently prescribed.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- Allied Health and Complementary Therapy Usage in Australian Women With Chronic Pelvic Pain: a Cross-Sectional Study via openalex
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System via openalex
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System via openalex
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms via openalex
- Endometriosis and the workplace: Lessons from Australia’s response to COVID‐19 via openalex
- Endometriosis research priorities in Australia via openalex
- Lessons from implementing the Australian National Action Plan for Endometriosis via openalex
- Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study via openalex
- The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey via openalex
- The Place of Cannabinoids in the Treatment of Gynecological Pain via openalex
- Treatment use and satisfaction in Australian women with endometriosis: a mixed‐methods study via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- W6853666501 via openalex
- W4206755368 via openalex
- W4210757569 via openalex
- W4225795233 via openalex
- W4361002789 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-22T00:33:08.630094+00:00
License: CC0
· commercial use OK